Search Prime Contracts

75A50124C00046

Definitive Contract

Overview

Government Description
LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
Place of Performance
Concord, CA 94520 United States
Pricing
Cost Sharing
Set Aside
None
Extent Competed
Full And Open Competition
Cerus Corporation was awarded Definitive Contract 75A50124C00046 (75A501-24-C-00046) worth up to $188,446,002 by the HHS Office of the Assistant Secretary for Preparedness and Response in September 2024. The contract has a duration of 6 years 3 months and was awarded through solicitation Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) full & open with NAICS 541714 and PSC 6505 via direct negotiation acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $156,324,479.

Status
(Open)

Last Modified 3/24/25
Period of Performance
9/30/24
Start Date
9/30/29
Current End Date
12/31/30
Potential End Date
10.0% Complete

Obligations and Backlog
$32.1M
Total Obligated
$32.1M
Current Award
$188.4M
Potential Award
17% Funded
$0.0
Funded Backlog
$156.3M
Total Backlog

Award Hierarchy

Definitive Contract

75A50124C00046

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75A50124C00046

Opportunity Lifecycle

Procurement history for 75A50124C00046

Transaction History

Modifications to 75A50124C00046

People

Suggested agency contacts for 75A50124C00046

Competition

Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
KJJQRRLY2FL5
Awardee CAGE
1PVJ6
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsjoann_kambaja
Last Modified By
hhsrichard_hall
Approved By
hhsrichard_hall

Legislative

Legislative Mandates
None Applicable
Performance District
CA-10
Senators
Dianne Feinstein
Alejandro Padilla
Representative
Mark DeSaulnier
Modified: 3/24/25